tiprankstipranks
Trending News
More News >
Data Horizon Co., Ltd. (JP:3628)
:3628
Japanese Market

Data Horizon Co., Ltd. (3628) AI Stock Analysis

Compare
0 Followers

Top Page

JP:3628

Data Horizon Co., Ltd.

(3628)

Select Model
Select Model
Select Model
Neutral 48 (OpenAI - 5.2)
Rating:48Neutral
Price Target:
¥478.00
▼(-3.43% Downside)
Action:UpgradedDate:03/05/26
The score is held back primarily by weak financial performance (loss-making margins, high leverage, and negative cash flows). Technical indicators are mixed but generally not supportive due to trading below key moving averages and a negative MACD. Valuation is a partial offset with a modest P/E, though the absence of a dividend yield reduces support.
Positive Factors
Recent revenue growth
Despite prior inconsistency, the latest period shows meaningful top-line growth (Fundamentals.RevenueGrowth ~11.9%). Sustained revenue expansion provides a runway to recover margins and leverage operating scale, improving long-term viability if cost control continues.
Industry exposure
Operating in medical healthcare information positions the company in a structurally growing sector driven by digitization and demand for health data services. This sector alignment supports durable market opportunities and recurring service demand over multi-quarter horizons.
Operational headcount
A workforce of 374 indicates substantive operational capacity to develop, deliver, and support healthcare information services. This scale can underpin recurring contracts and product delivery, enabling commercial execution and incremental margin improvement as revenue rises.
Negative Factors
Declining profitability
Consistent negative net profit and EBIT margins reduce retained earnings and limit reinvestment capacity. Prolonged unprofitability erodes stakeholder confidence, constrains strategic initiatives, and makes it harder to build durable economics without structural margin recovery.
Elevated leverage
High debt-to-equity increases financial risk and interest burden, reducing flexibility to invest or weather shocks. Elevated leverage heightens default and refinancing risk and can force conservative capital allocation, limiting long-term strategic growth options.
Negative cash flows
Negative operating and free cash flows impair the company's ability to fund operations, service debt, and invest organically. Persistent cash deficits typically necessitate external financing, diluting shareholders or increasing leverage, and weaken financial resilience over months.

Data Horizon Co., Ltd. (3628) vs. iShares MSCI Japan ETF (EWJ)

Data Horizon Co., Ltd. Business Overview & Revenue Model

Company DescriptionData Horizon Corporation provides data health support services to insurers in Japan. It develops and provides medical information services, such as health related data and generic drug notification services, as well as a health business support system. The company was founded in 1981 and is headquartered in Hiroshima, Japan. Data Horizon Corporation operates as a subsidiary of DeNA Co., Ltd.
How the Company Makes MoneyData Horizon Co., Ltd. generates revenue through several key streams. The primary source of income comes from software licensing fees, where clients pay for the right to use the company's proprietary analytics and AI software. Additionally, the company offers subscription-based services for its cloud-based platforms, providing ongoing access to updates and support. Professional services, including consulting and implementation support for clients looking to integrate Data Horizon's solutions into their operations, also contribute significantly to revenue. Furthermore, strategic partnerships with other tech firms and industry leaders enhance its market reach and open up collaborative revenue opportunities, particularly in joint ventures and bundled service offerings.

Data Horizon Co., Ltd. Financial Statement Overview

Summary
Weak fundamentals: profitability is declining with negative net profit and EBIT margins, leverage is elevated with a high debt-to-equity ratio and negative ROE, and cash flow is pressured with negative operating and free cash flow.
Income Statement
25
Negative
The company has experienced a declining trend in profitability, with negative net profit margins and EBIT margins over recent periods. Revenue growth has been inconsistent, with a notable growth in the latest period, but margins remain under pressure. The gross profit margin has also decreased over time, indicating challenges in maintaining cost efficiency.
Balance Sheet
30
Negative
The balance sheet shows a high debt-to-equity ratio, particularly in the latest period, indicating significant leverage. Return on equity is negative, reflecting ongoing losses. The equity ratio has decreased, suggesting increased financial risk and reduced stability.
Cash Flow
20
Very Negative
Cash flow metrics indicate significant challenges, with negative operating and free cash flows in recent periods. The free cash flow to net income ratio is volatile, and the operating cash flow coverage ratio is negative, highlighting cash flow management issues.
BreakdownTTMJun 2024Jun 2023Jun 2022Jun 2021Jun 2020
Income Statement
Total Revenue3.70B5.14B5.01B4.41B2.99B3.33B
Gross Profit1.04B1.36B1.49B1.42B1.26B1.78B
EBITDA-2.27B-3.15B-148.66M-222.73M-246.87M478.03M
Net Income-2.75B-3.95B-807.18M-664.86M-410.80M283.92M
Balance Sheet
Total Assets6.10B6.10B6.66B6.39B2.26B2.28B
Cash, Cash Equivalents and Short-Term Investments1.22B1.22B1.42B1.08B379.98M1.06B
Total Debt4.81B4.81B2.46B1.47B400.00M2.66M
Total Liabilities5.87B5.87B3.44B2.36B977.21M709.94M
Stockholders Equity221.67M221.67M3.19B3.97B1.26B1.54B
Cash Flow
Free Cash Flow-154.63M-1.89B-678.92M-923.59M-1.04B232.00M
Operating Cash Flow-145.58M-1.88B120.13M-198.37M-442.98M395.94M
Investing Cash Flow-177.67M-673.71M-789.14M-3.51B-572.80M-391.51M
Financing Cash Flow410.07M2.35B1.02B4.41B331.20M-56.21M

Data Horizon Co., Ltd. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price495.00
Price Trends
50DMA
500.20
Negative
100DMA
530.64
Negative
200DMA
536.72
Negative
Market Momentum
MACD
-2.95
Negative
RSI
48.12
Neutral
STOCH
18.67
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3628, the sentiment is Negative. The current price of 495 is above the 20-day moving average (MA) of 484.95, below the 50-day MA of 500.20, and below the 200-day MA of 536.72, indicating a bearish trend. The MACD of -2.95 indicates Negative momentum. The RSI at 48.12 is Neutral, neither overbought nor oversold. The STOCH value of 18.67 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:3628.

Data Horizon Co., Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
70
Outperform
¥1.12T18.9112.15%1.01%33.50%17.26%
63
Neutral
¥65.51B228.030.39%6.17%-8918.66%
63
Neutral
¥269.91B26.760.43%20.55%48.62%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
51
Neutral
¥63.74B77.038.79%31.95%-40.95%
51
Neutral
¥3.02B-4.2816.19%-4.42%
48
Neutral
¥6.12B10.51-4.07%-88.89%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:3628
Data Horizon Co., Ltd.
484.00
-71.00
-12.79%
JP:2413
M3
1,645.50
-69.17
-4.03%
JP:4480
Medley
1,947.00
-1,183.00
-37.80%
JP:3902
Medical Data Vision Co.Ltd.
1,680.00
1,264.00
303.85%
JP:4438
Welby Inc.
365.00
27.00
7.99%
JP:4483
JMDC Inc.
4,125.00
1,284.40
45.22%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 05, 2026